Telix Pharmaceuticals | TLX - Cash And Equivalent


Telix Pharmaceuticals reported AUD141.87M in Cash and Equivalent for its fiscal semester ending in December of 2025.





Cash And Equivalent Change Date
Cochlear AUD 275.7M 107.4M Jun/2025
CSL USD 2.16B 633M Jun/2025
Integral Diagnostics AUD 17.99M 15.86M Dec/2023
Mayne Pharma AUD 110.07M 838K Jun/2024
Medical Developments International AUD 17.84M 219K Jun/2025
Mesoblast USD 129.57M 31.58M Dec/2025
Neuren Pharmaceuticals AUD 4.23M 1.68M Dec/2025
Pacific Edge NZD 29.26M 8.79M Jun/2024
Paradigm Biopharmaceuticals AUD 16.82M 1M Jun/2025
Polynovo AUD 29.21M 16.7M Dec/2025
PYC Therapeutics AUD 153.05M 103.8M Jun/2025
Ramsay Health Care AUD 784.4M 443.3M Jun/2025
ResMed USD 1.66B 243.44M Mar/2026
Sonic Healthcare AUD 645M 25.39M Jun/2024